Biodistribution of curcumin and its derivatives new aspects for curcumin administration

2011 International Conference on Remote Sensing, Environment and Transportation Engineering, RSETE 2011 - Proceedings

Volumn , Issue , 2011, Pages 3878-3881

  Jiang, Fusheng ^a   Yu, Tingting ^a   Liu, Xia ^a   Ding, Zhisha ^a   Ma, Zhelong ^b   Shi, Ningchuan ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Biodistribution; Curcumin; Metabolism; PEGylation

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-TUMORS; BIODISTRIBUTIONS; CLINICAL APPLICATION; CURCUMIN; CURCUMIN DERIVATIVES; LOW MOLECULAR WEIGHT; LUNG DISEASE; LUNG TISSUE; OLEIC ACID ESTERIFICATION; PEGYLATION; POLYPHENOLIC COMPOUND; PULMONARY DELIVERY; THERAPEUTIC EFFECTS;

BIOCHEMISTRY; BIOLOGICAL ORGANS; CIVIL ENGINEERING; DRUG PRODUCTS; ESTERS; MAMMALS; METABOLISM; MOTION PICTURE EXPERTS GROUP STANDARDS; REMOTE SENSING; TISSUE; UNSATURATED FATTY ACIDS;

OLEIC ACID;

EID: 80052243580     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/RSETE.2011.5965165     Document Type: Conference Paper

References (12)

1. P. Anand, S. G. Thomas, A. B. Kunnumakkara, C. Sundaram, K. B. Harikumar, B. Sung, S. T. Tharakan, K. Misra, I. K. Priyadarsini, K. N. Rajasekharan, B. B. Aggarwal. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol., Vol 76, pp. 1590-1611, Aug. 2008.
2. P. Anand, A. B. Kunnumakkara, R. A. Newman, B. B. Aggarwal. Bioavailability of curcumin: problems and promises. Mol Pharm. Vol4, pp. 807-818, Nov. 2007.
3. A. Shehzad, F. Wahid, Y. S. Lee. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). Vol343, pp. 489-499, Sep. 2010.
4. R. A. Sharma, A. J. Gescher, W. P. Steward. Curcumin: the story so far. Eur J Cancer. Vol41, pp. 1955-1968, Sep. 2005.
5. Fusheng JIANG, Xiuling XU, Bo JIN, Nipi CHEN, Chengxian GAO, Zhishan DING, Guiyuan Lü. Water Soluble Curcumin Prodrug Synthesis and Its Antitumor Activity in Vitro. Chin Pharm J, Vol44, pp. 1492-1496, Oct. 2009 (In Chinese).
6. M. H. Pan, T. M. Huang, J. K Lin. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. Vol27, pp. 486-494, Apr. 1999.
7. Z. Ma, A. Shayeganpour, D. R. Brocks, A. Lavasanifar, J. Samuel. Highperformance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr, Vol21, pp. 546-552, May 2007.
8. B. Wahlström, G. Blennow. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). Vol43, pp. 86-92, Aug. 1978.
9. G. M. Holder, J. L. Plummer, A. J. Ryan. The metabolism and excretion of curcumin (1, 7-bis-(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione) in the rat. Xenobiotica. Vol8, pp. 761-768, Dec. 1978.
10. V. Ravindranath, N. Chandrasekhara. Absorption and tissue distribution of curcumin in rats. Toxicology. Vol 16, pp. 259-265, 1980.
11. M. H. Pan, T. M. Huang, J. K. Lin. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. Vol 27, pp. 486-494, Apr. 1999.
12. H. Hatcher, R. Planalp, J. Cho, F. M. Torti, S. V. Torti. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. Vol 65, pp. 1631-1652, Jun. 2008.